Jump to content

Melanie Welham

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 166.199.7.5 (talk) at 23:17, 25 July 2023 (Research and career: MOS consistency). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Melanie Welham
Born1964 (age 59–60)
Alma materImperial College London
University College London
Scientific career
InstitutionsUniversity of British Columbia
Biotechnology and Biological Sciences Research Council
University of Bath
ThesisFunctional and genetic analyses of the V-"src" oncogene (1988)

Melanie Joanne Welham (born April 1964) DBE is a British biochemist who is Executive Chair of the Biotechnology and Biological Sciences Research Council. She was previously a professor of biochemistry at the University of Bath, where she worked on stem cell biology.

Early life and education

Welham was born and raised in Suffolk.[1] Her father worked in agriculture, and she was the first member of her family to attend university. She studied biochemistry at Imperial College London, where only 15% of undergraduate students were women.[1] She moved to University College London for doctoral research, where she studied the oncogene.[2] She then moved to the University of British Columbia, where she worked as a postdoctoral researcher.[1]

Research and career

Welham joined the University of Bath as a lecturer[when?], where she worked on molecular signalling and stem cell science.[3] She was the first woman to be promoted to Professor at Bath.[3]

Welham joined Biotechnology and Biological Sciences Research Council (BBSRC) on secondment in 2012.[4] In 2018 Welham was made Executive Chair of BBSRC.[4][5]

She is committed to diversity and inclusion, and serves as Executive Champion for People, Culture and Talent at UK Research and Innovation.[4][6] She was made a trustee of the Royal Society of Biology in 2023.[7]

Selected publications

  • Bart Vanhaesebroeck; Melanie J. Welham; Kei Kotani; et al. (29 April 1997). "p110δ, a novel phosphoinositide 3-kinase in leukocytes". Proceedings of the National Academy of Sciences of the United States of America. 94 (9): 4330–5. Bibcode:1997PNAS...94.4330V. doi:10.1073/PNAS.94.9.4330. ISSN 0027-8424. PMC 20722. PMID 9113989. Wikidata Q24314825.
  • Nicholas R.D. Paling; Helen Wheadon; Heather K. Bone; Melanie J. Welham (24 August 2004). "Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling". Journal of Biological Chemistry. 279 (46): 48063–48070. doi:10.1074/JBC.M406467200. ISSN 0021-9258. PMID 15328362. Wikidata Q40522498.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  • Karen Wright; Nicholas Rooney; Mark Feeney; Jeremy Tate; Duncan Robertson; Melanie Welham; Stephen Ward (1 August 2005). "Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing". Gastroenterology. 129 (2): 437–453. doi:10.1053/J.GASTRO.2005.05.026. ISSN 0016-5085. PMID 16083701. Wikidata Q34440704.

References